|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
RelaxPLX gains Health Canada licence & South Korean sleep quality support claim
|
|
Monday, 29 June, 2026, 08 : 00 AM [IST]
|
|
Madrid, Spain
|
Monteloeder, SL, a subsidiary of Suannutra SA, announces RelaxPLX has officially received individual license approval for its sleep quality support by the Ministry of Food and Drug Safety (MFDS) of South Korea. In addition, this lemon verbena formulation attained a Health Canada Product License for multiple sleep and stress claims.
Stephanie Guillén-Díaz, chief commercial officer for Suannutra, said, “Attaining these health claims is an important regulatory milestone for RelaxPLX in North America and Asia Pacific. This strengthens the ingredient’s credibility and provides a valuable platform for business development with Canadian, South Korean and international partners. These claims differentiate RelaxPLX positioning because they combine two highly relevant consumer concerns: sleep quality and stress-related wellbeing. They go beyond a common sleep-quality claim by connecting sleep with some of the most relevant factors affecting consumers. This is exactly what brands are looking for.”
RelaxPLX is supported by three dedicated randomised, placebo-controlled clinical studies focused on sleep and stress-related outcomes. These studies were conducted across different populations, including adults with sleep and stress concerns, adults with sleep disturbances, and adolescents experiencing mild sleep and stress-related challenges.
Daniel González-Hedström, R&D director for Suannutra, said, “These studies provide strong backing for RelaxPLX’s efficacy, showing that its clinical story is not based only on subjective consumer perception. They combined validated questionnaires, objective sleep assessment, and physiological markers while addressing benefits that consumers can clearly understand—better sleep quality, stress-related balance, and feeling more restored in everyday life.”
|
|
|
|
|
|
|
|
|
|